[1]肖 静,何 魏,肖小富.盐酸普拉克索联合右佐匹克隆治疗帕金森病合并睡眠障碍的临床效果[J].医学信息,2024,37(21):119-122.[doi:10.3969/j.issn.1006-1959.2024.21.027]
　XIAO Jing,HE Wei,XIAO Xiaofu.Clinical Effect of Pramipexole Dihydrochloride Combined with Eszopiclone in the Treatment of Parkinson’s Disease with Sleep Disorder[J].Journal of Medical Information,2024,37(21):119-122.[doi:10.3969/j.issn.1006-1959.2024.21.027]
点击复制

盐酸普拉克索联合右佐匹克隆治疗帕金森病合并睡眠障碍的临床效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年21期
页码:
119-122
栏目:
药物与临床
出版日期:
2024-11-01

文章信息/Info

Title:
Clinical Effect of Pramipexole Dihydrochloride Combined with Eszopiclone in the Treatment of Parkinson’s Disease with Sleep Disorder
文章编号:
1006-1959（2024）21-0119-04
作者:
肖 静1; 何 魏2; 肖小富3
1.信丰县人民医院神经内科，江西 信丰 341600；2.信丰县中医院心电图室，江西 信丰 341600；3.信丰县小河镇中心卫生院内科，江西 信丰 341600
Author(s):
XIAO Jing1; HE Wei2; XIAO Xiaofu3
1.Department of Neurology,Xinfeng County People’s Hospital,Xinfeng 341600,Jiangxi,China;2.ECG Room of Xinfeng County Hospital of Traditional Chinese Medicine,Xinfeng 341600,Jiangxi,China;3.Department of Internal Medicine,Xinfeng County Xiaohe Town Central Hospital,Xinfeng 341600,Jiangxi,China
关键词:
帕金森病; 睡眠障碍; 盐酸普拉克索; 右佐匹克隆; 睡眠质量; 疲劳状态
Keywords:
Parkinson’s disease; Sleepdisorders; Pramipexole dihydrochloride; Dexzopiclone; Sleep quality; Fatigue state
分类号:
R742
DOI:
10.3969/j.issn.1006-1959.2024.21.027
文献标志码:
A
摘要:
目的 研究盐酸普拉克索联合右佐匹克隆治疗帕金森病（PD）合并睡眠障碍的临床效果。方法 以2022年1月-2023年8月信丰县人民医院神经内科收治的62例PD合并睡眠障碍患者为研究对象，经随机数字表法分为对照组和观察组，各31例。对照组采用盐酸普拉克索治疗，观察组在其基础上联合右佐匹克隆治疗，比较两组临床疗效、帕金森病评分量表（UPDRS）评分、匹兹堡睡眠质量指数量表（PSQI）评分及疲劳量表（FS-14）评分。结果 观察组治疗总有效率（93.55%）高于对照组（74.19%）（P＜0.05）。两组治疗后UPDRS评分（NEDL、ADL、ME）均低于治疗前，且观察组UPDRS评分（NEDL、ADL、ME）低于对照组（P＜0.05）。两组治疗后PSQI评分低于治疗前，且观察组治疗后PSQI评分低于对照组（P＜0.05）。两组治疗后FS-14评分（躯体疲劳、脑力疲劳）均低于治疗前，且观察组治疗后FS-14评分（躯体疲劳、脑力疲劳）低于对照组（P＜0.05）。结论 盐酸普拉克索联合右佐匹克隆在PD伴睡眠障碍治疗中具有确切疗效，其治疗效果好，可减轻患者PD症状，改善其睡眠质量，缓解其疲劳状态，值得应用。
Abstract:
Objective To study the clinical effect of pramipexole dihydrochloride combined with eszopiclone in the treatment of Parkinson’s disease (PD) with sleep disorders.Methods From January 2022 to August 2023, 62 patients with PD complicated with sleep disorder admitted to the Department of Neurology, Xinfeng County People’s Hospital were selected as the research objects. They were divided into control group and observation group by random number table method, with 31 patients in each group. The control group was treated with pramipexole dihydrochloride, and the observation group was treated with dexzopiclone on the basis of the control group. The clinical efficacy, the Unified Parkinson’s Disease Rating Scale(UPDRS) score, Pittsburgh Sleep Quality Index Scale (PSQI) score and Fatigue Scale (FS-14) score were compared between the two groups.Results The total effective rate of treatment in the observation group (93.55%) was higher than that in the control group (74.19%) (P<0.05). After treatment, the UPDRS scores (NEDL, ADL, ME) of the two groups were lower than those before treatment, and the UPDRS scores (NEDL, ADL, ME) of the observation group were lower than those of the control group (P<0.05). The PSQI score of the two groups after treatment was lower than that before treatment, and the PSQI score of the observation group after treatment was lower than that of the control group (P<0.05). The FS-14 scores (physical fatigue, mental fatigue) of the two groups after treatment were lower than those before treatment, and the FS-14 scores (physical fatigue, mental fatigue) of the observation group after treatment were lower than those of the control group (P<0.05).Conclusion Pramipexoledihydrochloride combined with dexzopiclone has a definite curative effect in the treatment of PD with sleep disorders. It has a good therapeutic effect, which can reduce the symptoms of PD, improve the quality of sleep, relieve the fatigue state, and is worthy of application.

参考文献/References:

[1]郭鹏,余舒扬,左丽君,等.帕金森病伴发睡眠障碍的临床特点、相关因素及视频多导睡眠图的变化[J].中国神经免疫学和神经病学杂志,2018,25(1):26-31.[2]尤林,白抚生,韩艳丽,等.帕金森病患者睡眠障碍临床特点及相关因素[J].中国公共卫生,2018,34(1):121-122.[3]尤红,梅俊华,徐金梅,等.阿戈美拉汀联合普拉克索治疗特发性快速眼球运动睡眠期行为障碍合并焦虑抑郁30例[J].医药导报,2023,42(2):198-202.[4]金莹,李凯,李淑华,等.帕金森病患者睡眠障碍与抑郁焦虑和生活质量的相关性[J].中国神经免疫学和神经病学杂志,2021,28(6):459-463.[5]许可,张扬,欧春影,等.普拉克索联合美多巴治疗帕金森病的疗效及对生活质量的影响[J].实用临床医药杂志,2018,22(1):48-50,54.[6]姬利,韩霞,张亚峰,等.美多巴联合普拉克索治疗帕金森病的疗效及对患者运动功能、血清同型半胱氨酸和血尿酸水平的影响[J].海南医学,2022,33(10):1241-1244.[7]徐金梅,周晓香.枣仁安神颗粒联合右佐匹克隆治疗老年原发性失眠症的临床研究[J].现代药物与临床,2022,37(9):2012-2016.[8]王晓东,王海斌,杨岳.右佐匹克隆辅助治疗精神分裂症伴睡眠障碍的临床疗效观察[J].贵州医药,2022,46(4):568-569.[9]中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍学组,刘春风,等.中国帕金森病睡眠障碍管理专家共识[J].中华神经科杂志,2022,55(5):441-451.[10]王治东,孙文华,马建军,等.帕金森病患者睡眠障碍与精神症状相关性研究[J].中国神经精神疾病杂志,2021,47(2):78-82.[11]司慧丽,纪别克,赵鸿雁,等.帕金森病患者睡眠障碍特点及其影响因素分析[J].广东医学,2020,41(1):61-65.[12]袁德智,胡洁,赵秋叶,等.帕金森病进展速度与抑郁、睡眠障碍的相关性分析[J].中国医科大学学报,2020,49(4):326-330.[13]马宇,李兴贵,展群岭,等.普拉克索与美多芭合用配合心理治疗应用于帕金森病合并睡眠障碍患者的效果[J].检验医学与临床,2018,15(1):30-33.[14]王阳,徐冰,周进,等.司来吉兰联合普拉克索对帕金森病合并睡眠障碍患者精神行为症状认知障碍及日常生活能力的影响[J].河北医学,2019,25(7):1078-1081.[15]谭文用,邹晓毅,周沐科,等.神经节苷脂联合盐酸普拉克索对帕金森患者非运动症状及血清Cys C、S-100B、NSE含量的影响[J].实用医院临床杂志,2018,15(2):125-128.[16]曹国军,张行丰,郑科达.普拉克索对老年血管性帕金森患者非运动症状及氧化应激的影响[J].中国现代应用药学,2018,35(10):1554-1559.[17]曹珊珊,于东东,苏嵘,等.帕金森病病人睡眠障碍发生率及相关影响因素分析[J].中西医结合心脑血管病杂志,2019,17(8):1257-1259.[18]雷蕾,李直,王文哲,等.右佐匹克隆与佐匹克隆对失眠症患者血清5-HT、BDNF及SAS评分的影响分析[J].检验医学与临床,2019,16(24):3694-3696.[19]黎柱培,苗国栋,蔡玉珍,等.右佐匹克隆联合米氮平对慢性失眠障碍的疗效分析[J].国际精神病学杂志,2020,47(2):325-328,332.[20]赵剑华,张静霞,刘敏科.右佐匹克隆治疗慢性失眠患者的临床疗效及安全性[J].中国新药与临床杂志,2019,38(5):288-291.[21]刘莹莹,高喜斌,马利,等.普拉克索联合高压氧舱治疗帕金森病合并睡眠障碍的效果[J].中国医药导报,2018,15(11):78-81,90.[22]张颖,苏俊,王锦权,等.认知行为疗法联合右佐匹克隆片治疗ICU转出患者睡眠障碍的疗效观察[J].浙江医学,2018,40(7):717-721.[23]王超,耿彩虹.脑电生物反馈联合右佐匹克隆治疗老年失眠症患者的疗效分析[J].山西医药杂志,2022,51(11):1287-1289.[24]胥昕怡,占美,张臣宇,等.左旋多巴联合司来吉兰或普拉克索治疗帕金森病的药物剂量多中心研究[J].中国医院药学杂志,2023,43(12):1366-1371.[25]孙慧娟,李曦丹,林永忠.重复经颅磁刺激联合右佐匹克隆治疗慢性失眠障碍的临床疗效及脑电变化[J].中华行为医学与脑科学杂志,2021,30(12):1082-1088.[26]何明,郑芝伟.右佐匹克隆与艾司唑仑治疗老年痴呆伴睡眠障碍患者的比较[J].国际精神病学杂志,2021,48(2):264-266.

相似文献/References:

[1]王姝,莫英绪,王大成.帕金森病发病因素的研究现状[J].医学信息,2018,31(01):46.[doi:10.3969/j.issn.1006-1959.2018.01.017]
　WANG Shu,MO Ying-xu,WANG Da-cheng.Research Status of the Factors of Parkinson's Disease[J].Journal of Medical Information,2018,31(21):46.[doi:10.3969/j.issn.1006-1959.2018.01.017]
[2]刘 阳,王惠凌,安 迪,等.进行性核上性麻痹1例报告[J].医学信息,2018,31(05):192.[doi:10.3969/j.issn.1006-1959.2018.05.073]
[3]任重阳,葛义俊,张 梅.失眠与腺苷信号及免疫功能的研究进展[J].医学信息,2018,31(10):4.[doi:10.3969/j.issn.1006-1959.2018.10.002]
　REN Chong-yang,GE Yi-jun,ZHANG Mei.Research Progress of Insomnia and Adenosine Signaling and Immune Function[J].Journal of Medical Information,2018,31(21):4.[doi:10.3969/j.issn.1006-1959.2018.10.002]
[4]樊 毅.帕金森病嗅觉改变的相关性研究[J].医学信息,2018,31(17):95.[doi:10.3969/j.issn.1006-1959.2018.17.029]
　FAN Yi.Correlation Study of Olfactory Changes in Parkinson's Disease[J].Journal of Medical Information,2018,31(21):95.[doi:10.3969/j.issn.1006-1959.2018.17.029]
[5]张琼月,蒋运兰,谢兰兰,等.体感音乐疗法对睡眠障碍患者干预效果的系统评价[J].医学信息,2018,31(17):163.[doi:10.3969/j.issn.1006-1959.2018.17.052]
　ZHANG Qiong-yue,JIANG Yun-lan,XIE Lan-lan,et al.Systematic Evaluation of the Effect of Vibroacoustic Therapy on Patients with Sleep Disorders[J].Journal of Medical Information,2018,31(21):163.[doi:10.3969/j.issn.1006-1959.2018.17.052]
[6]秦亚东.多奈哌齐联合阿米替林治疗神经衰弱伴发认知障碍患者的临床效果[J].医学信息,2019,32(10):144.[doi:10.3969/j.issn.1006-1959.2019.10.047]
　QIN Ya-dong.Clinical Effect of Donepezil Combined with Amitriptyline in the Treatment of Patients with Neurasthenia and Cognitive Impairment[J].Journal of Medical Information,2019,32(21):144.[doi:10.3969/j.issn.1006-1959.2019.10.047]
[7]陈凤全.帕金森病的诊治现状及进展[J].医学信息,2020,33(12):43.[doi:10.3969/j.issn.1006-1959.2020.12.014]
　CHEN Feng-quan.Status and Progress of Diagnosis and Treatment of Parkinson’s Disease[J].Journal of Medical Information,2020,33(21):43.[doi:10.3969/j.issn.1006-1959.2020.12.014]
[8]王锡锦.情绪管理对脑梗死患者焦虑、抑郁及睡眠障碍的影响[J].医学信息,2020,33(17):186.[doi:10.3969/j.issn.1006-1959.2020.17.058]
　WANG Xi-jin.Influence of Emotional Management on Anxiety,Depression and Sleep Disturbance in Patients with Cerebral Infarction[J].Journal of Medical Information,2020,33(21):186.[doi:10.3969/j.issn.1006-1959.2020.17.058]
[9]邓伟胜,楼云龙,苏中振.正电子发射断层扫描PET/CT在帕金森病患者早期诊断中的应用[J].医学信息,2020,33(18):170.[doi:10.3969/j.issn.1006-1959.2020.18.057]
　DENG Wei-sheng,LOU Yun-long,SU Zhong-zhen.Application of Positron Emission Tomography PET/CT in Early Diagnosis of Parkinson’s Disease[J].Journal of Medical Information,2020,33(21):170.[doi:10.3969/j.issn.1006-1959.2020.18.057]
[10]郜晓雯,杨傲立,陈 曼,等.十堰市社区老年人睡眠障碍现状及影响因素的调查分析[J].医学信息,2020,33(20):115.[doi:10.3969/j.issn.1006-1959.2020.20.035]
　GAO Xiao-wen,YANG Ao-li,CHEN Man,et al.Investigation and Analysis of the Status Quo and Influencing Factors of the Elderly Sleep Disorders in the Community of Shiyan City[J].Journal of Medical Information,2020,33(21):115.[doi:10.3969/j.issn.1006-1959.2020.20.035]

更新日期/Last Update: 1900-01-01